Thomas Boesen
Chief Operating Officer at SYNACT PHARMA AB
Network origin in Thomas Boesen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas Boesen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CHEMOMETEC A/S | Medical Specialties | Chief Executive Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
William Blair & Co. LLC
 William Blair & Co. LLC Investment Banks/BrokersFinance William Blair & Co. LLC (William Blair) is a SEC-registered broker/dealer firm headquartered in Chicago, Illinois. The firm was founded by William McCormick Blair in 1935 and is a subsidiary of WBC Holdings LP. Until 1941, they were known as Blair, Bonner & Co. William Blair provides broking services to individual, institutional and issuing clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
Vector Securities LLC
 Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999. | Investment Banks/Brokers | Corporate Officer/Principal | |
| The University of Chicago | College/University | Graduate Degree | |
| University of Hartford | College/University | Masters Business Admin | |
| Copenhagen Business School | College/University | Graduate Degree Masters Business Admin | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| TALPHERA, INC. | Pharmaceuticals: Major | Director/Board Member | |
QIAGEN Aarhus A/S
 QIAGEN Aarhus A/S Packaged SoftwareTechnology Services QIAGEN Aarhus A/S develops and markets software and hardware solutions and consultancy services within bioinformatics. Its products include workbench, server solutions, database, and modules. The company was founded by Thomas Knudsen and Bjarne Knudsen in 2004 and is headquartered in Aarhus, Denmark. | Packaged Software | Founder | |
Getinge Cetrea A/S
 Getinge Cetrea A/S Packaged SoftwareTechnology Services Getinge Cetrea A/S develops clinical logistics and communication software products. Its products include insight enterprise, insight emergency, insight surgical, insight ICU and insight patient ward. The company was founded by Kakob E. Bardram in 2006 and is headquartered in Aarhus Nord, Denmark. | Packaged Software | Founder | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| PNN Medical A/S | Chief Executive Officer | ||
| Vingmed Danmark A/S | Corporate Officer/Principal | ||
| Enovacor ApS | Director/Board Member | ||
| Vikarbasen A/S | Chairman | ||
| PNN Medical SA | Chief Executive Officer | ||
| Sundialog A/S | Director/Board Member | ||
Cercare Medical A/S
 Cercare Medical A/S Packaged SoftwareTechnology Services Cercare Medical ApS provides automated identification of viable tissue in acute stroke. It develops technology within medical image processing and image database analytics. The firm creates diagnostic software. The company was founded by Kim Mouridsen and Mikkel Bo Hansen in October 2013 and is headquartered in Aarhus, Denmark. | Packaged Software | Chairman | |
Neurescue ApS
 Neurescue ApS Medical SpecialtiesHealth Technology Neurescue ApS develops innovative medical devices for the treatment of cardiac arrest. It offers new platform of treatment methods for paramedics, nurses and doctors alike. The company was founded by Habib Frost in 2013 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Chairman | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
| Swib Holding AB | Director/Board Member | ||
| Corporate Culture ApS | Corporate Officer/Principal | ||
| MONSENSO A/S | Internet Software/Services | Director/Board Member | |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| Quantass ApS | Corporate Officer/Principal | ||
| OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
CytoKi Pharma ApS
 CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Mindway AI ApS
 Mindway AI ApS Information Technology ServicesTechnology Services Mindway AI ApS operates as a software company, which engages in the development of technical solutions for gambling purposes. Its artificial intelligence system works with betting operators, platform providers, regulators, and governments to apply early detection and intervention for safer gambling and gaming activities. The company was founded by Kim Mouridsen and is headquartered in Aarhus, Denmark. | Information Technology Services | Chief Executive Officer | |
CPHI-Holding A/S
 CPHI-Holding A/S Miscellaneous Commercial ServicesCommercial Services CPHI-Holding A/S is a Danish company based in Rodovre, Denmark. The CEOs are Michael Østerlund Madsen, Peter Scheuer Jensen. CPHI-Holding develops airport solutions to enhance passenger experience, including security scanner systems, intelligent trolleys, and baggage handling technologies. The private company has a team of over 30 employees. The company was founded in 1999 by Lars Hojgaard Thogersen, Søren Jakobsen, Rasmus Halfdan Breck. | Miscellaneous Commercial Services | Director/Board Member | |
Trill Capital AB
 Trill Capital AB Real Estate DevelopmentFinance Trill Capital AB is a Swedish company that owns and manages real and movable property. The private company is based in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
ACT.Global A/S
 ACT.Global A/S Industrial MachineryProducer Manufacturing ACT.Global A/S provides disinfection and air purification solutions. Its product, Premium Purity, reduces the use of toxic chemicals, water, and plastic that are beneficial to sectors such as healthcare, hospitality, food processing, and beverages. The company was founded by Carsten Jensen in 2013 and is headquartered in Kastrup, Denmark. | Industrial Machinery | Director/Board Member | |
| Perfusion Tech ApS | Director/Board Member | ||
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Go-PEN Aps
 Go-PEN Aps Medical SpecialtiesHealth Technology Go-Pen ApS develops insulin pen. The Danish company was founded in 2019 by Ole Kjerkegaard Nielsen, Michael Ejstrup Hansen. Ole Kjerkegaard Nielsen has been the CEO since 2019. | Medical Specialties | Chairman | |
Tetra Pharm Technologies ApS
 Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Tetra Pharm Technologies ApS designs and develops new drug formulations, conducts clinical trials, and commercializes medicines. The company is based in Hillerod, Denmark. The CEOs are Jesper Breum Kanchanarat and Martin Stefan Rose. The Danish company was founded in 2019. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ALZINOVA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| TXP Pharma GmbH | Founder Chief Executive Officer Founder Corporate Officer/Principal |
Statistics
International
| Denmark | 27 |
| United States | 12 |
| Sweden | 12 |
| Netherlands | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 13 |
| Finance | 10 |
| Consumer Services | 7 |
| Technology Services | 6 |
| Commercial Services | 5 |
Operational
| Director/Board Member | 78 |
| Corporate Officer/Principal | 41 |
| Chairman | 28 |
| Chief Executive Officer | 26 |
| Director of Finance/CFO | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Torbjørn Bjerke | 27 |
| Jeppe Øvlesen | 27 |
| Björn Westberg | 21 |
| Uli Alf Hacksell | 20 |
| Terje Kalland | 20 |
| Nils Thomas von Koch | 17 |
| Marina Bozilenko | 13 |
| James Knight | 11 |
| Henrik Stage | 10 |
| Kirsten Harting | 7 |
| Kerstin Hasselgren | 6 |
| Thomas Jonassen | 5 |
| Anders Dyhr Toft | 4 |
| Patrik Renblad | 4 |
| Thierry Duvauchelle | 2 |
- Stock Market
- Insiders
- Thomas Boesen
- Company connections
